Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 CME | Financial | $317.97 | 1.58M | $112.93B | 25.93 | 3.55% | Moderate Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CME | CME Group | 317.97 | 43.58 | 15.88% |
| Name | Price | % Change | |
|---|---|---|---|
| CME | $317.97 | +15.88% |
CME Group (CME) announced that its Lean Hog futures and options reached a new daily volume record of 209,363 contracts on November 9, 2026, surpassing the previous record of 204,948
The U.S. options markets had their busiest day on record on Thursday as stocks slumped, with average daily volumes rising 53% above the average level a month earlier, Bloomberg’s Bernard
Two of the private market’s most closely watched unicorns made headlines this week, as Shield AI unveiled plans for a multibillion-dollar acquisition and Kalshi boosted its valuation to $40B following
CME Group (CME) reported its average daily volume reached a new October record of 30M contracts, an increase of 15% from October 2025, when the previous record was set with
Prediction-market startup Kalshi has raised $1 billion in fresh funding, pushing its valuation to $40 billion as it moves deeper into traditional financial markets. The New York-based company is expanding
XRP (XRP-USD) traded near $1.29 on Monday, testing key price support ahead of the Federal Reserve’s October 28 interest rate decision as traders weighed mixed exchange flows against a new
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by
BofA raised the firm’s price target on CME Group (CME) to $227 from $218 and keeps an Underperform rating on the shares. CME reported a small profit beat driven by
Piper Sandler raised the firm’s price target on CME Group (CME) to $330 from $295 and keeps an Overweight rating on the shares. The firm cites an overall solid beat
UBS raised the firm’s price target on CME Group (CME) to $310 from $270 and keeps a Neutral rating on the shares. CME delivered solid revenue growth and an EPS
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| CME | sell | Reiterated | Oct 23, 2026 | |||
| CME | buy | Reiterated | Oct 22, 2026 | |||
| CME | buy | Reiterated | Oct 22, 2026 | |||
| CME | hold | Reiterated | Oct 22, 2026 | |||
| CME | hold | Reiterated | Oct 22, 2026 | |||
| CME | buy | Reiterated | Oct 22, 2026 | |||
| CME | buy | Assigned | Oct 22, 2026 | |||
| CME | buy | Upgraded | Oct 22, 2026 | |||
| CME | sell | Reiterated | Oct 21, 2026 | |||
| CME | hold | Reiterated | Oct 20, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| CME | Feb 10, 2027TBA | $112.93B | $3.03 | $1.76B | 1.59 | 25.93 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
